NSMAF

gene
On this page

Also known as FANGRAMD5

Summary

NSMAF (neutral sphingomyelinase activation associated factor, HGNC:8017) is a protein-coding gene on chromosome 8q12.1, encoding Protein FAN (Q92636). Couples the p55 TNF-receptor (TNF-R55 / TNFR1) to neutral sphingomyelinase (N-SMASE).

This gene encodes a WD-repeat protein that binds the cytoplasmic sphingomyelinase activation domain of the 55kD tumor necrosis factor receptor. This protein is required for TNF-mediated activation of neutral sphingomyelinase and may play a role in regulating TNF-induced cellular responses such as inflammation. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 8439 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 162 total
  • MANE Select transcript: NM_003580

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:8017
Approved symbolNSMAF
Nameneutral sphingomyelinase activation associated factor
Location8q12.1
Locus typegene with protein product
StatusApproved
AliasesFAN, GRAMD5
Ensembl geneENSG00000035681
Ensembl biotypeprotein_coding
OMIM603043
Entrez8439

Gene structure

Transcript identifiers

Ensembl transcripts: 27 — 11 protein_coding, 10 retained_intron, 3 nonsense_mediated_decay, 3 protein_coding_CDS_not_defined

ENST00000038176, ENST00000427130, ENST00000517612, ENST00000518159, ENST00000518229, ENST00000519166, ENST00000519174, ENST00000519227, ENST00000519858, ENST00000519871, ENST00000521712, ENST00000521972, ENST00000522645, ENST00000523106, ENST00000523177, ENST00000523982, ENST00000524148, ENST00000649465, ENST00000870782, ENST00000870783, ENST00000870784, ENST00000958101, ENST00000958102, ENST00000958103, ENST00000958104, ENST00000958105, ENST00000958106

RefSeq mRNA: 21 — MANE Select: NM_003580 NM_001144772, NM_001412988, NM_001412989, NM_001412990, NM_001412991, NM_001412992, NM_001412993, NM_001412994, NM_001412995, NM_001412996, NM_001412997, NM_001412998, NM_001412999, NM_001413000, NM_001413001, NM_001413002, NM_001413003, NM_001413004, NM_001413005, NM_001413006, NM_003580

CCDS: CCDS47864, CCDS6173

Canonical transcript exons

ENST00000038176 — 31 exons

ExonStartEnd
ENSE000009804185858645858586608
ENSE000009804205858589858586000
ENSE000009804225858565258585761
ENSE000011182425862337758623424
ENSE000011182545860128558601348
ENSE000011182565862370958623780
ENSE000011980485865957358659853
ENSE000012420785858350858584200
ENSE000034631295859738758597550
ENSE000034731135859786058597902
ENSE000035029045859556058595659
ENSE000035311105858761858587701
ENSE000035337605859000758590074
ENSE000035414335860776958607840
ENSE000035449825860205858602137
ENSE000035712545863530558635372
ENSE000035769915863149658631546
ENSE000035789775860144558601535
ENSE000035790855859923258599363
ENSE000035876865858945258589575
ENSE000035887045859975058599870
ENSE000035986135862322058623272
ENSE000036111045864298458643073
ENSE000036210435863518958635225
ENSE000036357905860321058603386
ENSE000036470995863546858635546
ENSE000036479655860960458609733
ENSE000036592685859086758590934
ENSE000036635695860592758606035
ENSE000036734825859997058600021
ENSE000036837075859423258594290

Expression profiles

Bgee: expression breadth ubiquitous, 294 present calls, max score 95.80.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.8803 / max 920.7762, expressed in 1819 samples.

FANTOM5 promoters (23 alternative TSS)

Promoter IDTPM avgSamples expressed
9321416.48181804
932133.77891625
931993.1577127
931952.220288
932112.21911195
932121.1481747
931970.7881121
932010.7470105
932090.7092403
931960.588386

Top tissues by expression

298 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
gingival epitheliumUBERON:000194995.80gold quality
tibiaUBERON:000097995.72gold quality
esophagus squamous epitheliumUBERON:000692095.58gold quality
calcaneal tendonUBERON:000370195.06gold quality
squamous epitheliumUBERON:000691494.96gold quality
germinal epithelium of ovaryUBERON:000130494.73gold quality
stromal cell of endometriumCL:000225594.53gold quality
visceral pleuraUBERON:000240194.48gold quality
gingivaUBERON:000182894.36gold quality
choroid plexus epitheliumUBERON:000391194.27gold quality
skin of hipUBERON:000155494.25gold quality
parietal pleuraUBERON:000240094.05gold quality
pleuraUBERON:000097793.99gold quality
body of pancreasUBERON:000115093.91gold quality
palpebral conjunctivaUBERON:000181293.82gold quality
epithelium of esophagusUBERON:000197693.68gold quality
superficial temporal arteryUBERON:000161493.49gold quality
tonsilUBERON:000237293.44gold quality
epithelium of nasopharynxUBERON:000195193.33gold quality
adrenal tissueUBERON:001830393.32gold quality
periodontal ligamentUBERON:000826693.22gold quality
monocyteCL:000057693.11gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.06gold quality
skin of abdomenUBERON:000141693.06gold quality
leukocyteCL:000073893.01gold quality
bloodUBERON:000017893.00gold quality
mononuclear cellCL:000084292.99gold quality
granulocyteCL:000009492.88gold quality
skin of legUBERON:000151192.76gold quality
rectumUBERON:000105292.71gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.82
E-GEOD-100618no230.32

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

48 targeting NSMAF, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-32-5P99.9875.211964
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-6768-5P99.9267.361942
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-659-3P99.8570.691620
HSA-MIR-3121-3P99.8271.963630
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-674599.7465.331321
HSA-MIR-6766-5P99.6867.702325
HSA-MIR-7-5P99.6770.531809
HSA-MIR-7157-5P99.6669.331829
HSA-MIR-130399.6569.771662
HSA-MIR-58699.6570.402051
HSA-MIR-570099.6469.882280
HSA-MIR-497-3P99.6169.711990
HSA-MIR-431099.5968.842527
HSA-MIR-18A-3P99.5665.681092
HSA-MIR-467299.5071.582893
HSA-MIR-312399.4767.152693
HSA-MIR-363-5P99.4664.511015
HSA-MIR-5589-3P99.2968.301443
HSA-MIR-892C-5P99.1670.562116
HSA-MIR-10B-3P99.0466.98988

Literature-anchored findings (GeneRIF, showing 5)

  • The interaction of FAN with receptor for activated C-kinase 1 (RACK1) appears to be dependent on the folding of the WD repeats into a secondary structure, because no linear binding motifs are identified in the WD-repeat region of FAN. (PMID:12391233)
  • sphingolipid activator proteins like domain may stabilize the fold of acid sphingomyelinase (PMID:15653433)
  • Regulation of NSMAF by TNF-alpha involves PRKCD in lung epithelial cells. (PMID:18653803)
  • The rs1050504 C > T genotype was observed to be significantly associated with an increased risk for developing pulmonary tuberculosis. (PMID:29115933)
  • these data identify a novel caspase-2-interacting factor, FAN, and expand the role for the enzyme in seemingly non-apoptotic cellular mechanisms. (PMID:29621545)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerionsmafENSDARG00000051920
mus_musculusNsmafENSMUSG00000028245
rattus_norvegicusNsmafENSRNOG00000010234
caenorhabditis_elegansWBGENE00004760
caenorhabditis_elegansWBGENE00007752

Paralogs (7): WDFY4 (ENSG00000128815), LYST (ENSG00000143669), NBEAL1 (ENSG00000144426), NBEAL2 (ENSG00000160796), WDFY3 (ENSG00000163625), NBEA (ENSG00000172915), LRBA (ENSG00000198589)

Protein

Protein identifiers

Protein FANQ92636 (reviewed: Q92636)

Alternative names: Factor associated with neutral sphingomyelinase activation

All UniProt accessions (3): E5RGF5, E5RGU2, Q92636

UniProt curated annotations — full annotation on UniProt →

Function. Couples the p55 TNF-receptor (TNF-R55 / TNFR1) to neutral sphingomyelinase (N-SMASE). Specifically binds to the N-smase activation domain of TNF-R55. May regulate ceramide production by N-SMASE.

Tissue specificity. Ubiquitous.

Isoforms (2)

UniProt IDNamesCanonical?
Q92636-11yes
Q92636-22

RefSeq proteins (21): NP_001138244, NP_001399917, NP_001399918, NP_001399919, NP_001399920, NP_001399921, NP_001399922, NP_001399923, NP_001399924, NP_001399925, NP_001399926, NP_001399927, NP_001399928, NP_001399929, NP_001399930, NP_001399931, NP_001399932, NP_001399933, NP_001399934, NP_001399935, NP_003571* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000409BEACH_domDomain
IPR001680WD40_rptRepeat
IPR004182GRAMDomain
IPR011993PH-like_dom_sfHomologous_superfamily
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR023362PH-BEACH_domDomain
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR036372BEACH_dom_sfHomologous_superfamily
IPR050865BEACH_DomainFamily
IPR057496FAN-like_PHDomain

Pfam: PF00400, PF02138, PF02893, PF25400

UniProt features (13 total): repeat 6, domain 3, chain 1, splice variant 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q92636-F188.460.71

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5626978TNFR1-mediated ceramide production

MSigDB gene sets: 194 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, GOBP_RESPONSE_TO_PEPTIDE, GTGCCTT_MIR506, ONKEN_UVEAL_MELANOMA_UP, GOBP_SPHINGOLIPID_METABOLIC_PROCESS, MARTINEZ_RB1_TARGETS_DN, PID_TNF_PATHWAY, GOBP_AMIDE_METABOLIC_PROCESS, LIAO_METASTASIS, GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY, NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON, GOBP_LIPID_METABOLIC_PROCESS, GOBP_CERAMIDE_METABOLIC_PROCESS

GO Biological Process (6): ceramide metabolic process (GO:0006672), signal transduction (GO:0007165), tumor necrosis factor-mediated signaling pathway (GO:0033209), obsolete positive regulation of amide metabolic process (GO:0034250), positive regulation of lipid metabolic process (GO:0045834), obsolete regulation of membrane lipid metabolic process (GO:1905038)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (3): cytoplasm (GO:0005737), cytosol (GO:0005829), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
TNF signaling1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
sphingolipid metabolic process1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
cytokine-mediated signaling pathway1
cellular response to tumor necrosis factor1
lipid metabolic process1
positive regulation of metabolic process1
regulation of lipid metabolic process1
binding1
intracellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

1050 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NSMAFSMPD2O60906917
NSMAFTNFRSF1AP19438864
NSMAFFAM110BQ8TC76591
NSMAFUBXN2BQ14CS0565
NSMAFRACK1P25388564
NSMAFARMC6Q6NXE6465
NSMAFSDR16C5Q8N3Y7426
NSMAFSMPD3Q9NY59398
NSMAFBRINP1O60477397
NSMAFPLCXD2Q0VAA5397
NSMAFTMEM68Q96MH6390
NSMAFBPNT2Q9NX62381
NSMAFPRKACAP17612381
NSMAFPRKACBP22694380
NSMAFPRKACGP22612379

IntAct

34 interactions, top by confidence:

ABTypeScore
HEXIM1CCNT1psi-mi:“MI:0914”(association)0.930
NSMAFGABARAPL1psi-mi:“MI:0407”(direct interaction)0.720
GABARAPL1IPO5psi-mi:“MI:0914”(association)0.590
NSMAFDCP1Bpsi-mi:“MI:0407”(direct interaction)0.530
DCP1ANSMAFpsi-mi:“MI:0915”(physical association)0.530
NSMAFpsi-mi:“MI:0915”(physical association)0.530
DCP1BNSMAFpsi-mi:“MI:0915”(physical association)0.530
NSMAFpsi-mi:“MI:0407”(direct interaction)0.530
DCP1ANSMAFpsi-mi:“MI:0407”(direct interaction)0.530
NSMAFDUSP14psi-mi:“MI:0914”(association)0.530
NSMAFGABARAPpsi-mi:“MI:0407”(direct interaction)0.520
VASPNSMAFpsi-mi:“MI:0915”(physical association)0.500
ACTBNSMAFpsi-mi:“MI:0915”(physical association)0.500
NSMAFVASPpsi-mi:“MI:0914”(association)0.500
NSMAFGABARAPL2psi-mi:“MI:0407”(direct interaction)0.440
NSMAFMAP1LC3Bpsi-mi:“MI:0407”(direct interaction)0.440
MAP1LC3CNSMAFpsi-mi:“MI:0407”(direct interaction)0.440
TNFRSF1ANSMAFpsi-mi:“MI:0915”(physical association)0.400
NSMAFEPB41L2psi-mi:“MI:0914”(association)0.350
NEK4E2F8psi-mi:“MI:0914”(association)0.350
GABARAPL1GABARAPpsi-mi:“MI:0914”(association)0.350
MAP1LC3Apsi-mi:“MI:0914”(association)0.350
GABARAPL1psi-mi:“MI:0914”(association)0.350
GABARAPpsi-mi:“MI:0914”(association)0.350
NSMAFXIRP2psi-mi:“MI:0914”(association)0.350

BioGRID (69): NSMAF (Affinity Capture-MS), GNB2L1 (Two-hybrid), NSMAF (Affinity Capture-Western), CCT6A (Affinity Capture-MS), EPB41L2 (Affinity Capture-MS), PFDN2 (Affinity Capture-MS), TCP1 (Affinity Capture-MS), CCT3 (Affinity Capture-MS), CCT7 (Affinity Capture-MS), CCT4 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), CCT8 (Affinity Capture-MS), CCT5 (Affinity Capture-MS), FBXL19 (Affinity Capture-MS), DOCK8 (Affinity Capture-MS)

ESM2 similar proteins: A0A0G2K344, D3ZGS3, F1M386, F1MSG6, F1PBJ0, G5EF51, O00329, O02697, O35242, O35904, O70481, O88763, O94830, P32871, P42336, P42337, P42338, P42339, P42347, P42348, P48736, P50520, P54676, P70600, Q01968, Q14289, Q14BI7, Q16JS8, Q3MHU3, Q3UYK3, Q4KWH5, Q4KWH8, Q5D891, Q5ZI89, Q6AZN6, Q6GQ76, Q6NVF0, Q6PF93, Q7Z392, Q80Y98

Diamond homologs: A8XSV3, D4A929, E7FAW3, E9Q2M9, F4HZB2, F4IG73, F4JD14, F4JHT3, O35242, P0C6P0, P25356, P50851, P97412, Q19317, Q54PP7, Q54RQ8, Q55AV3, Q55DM1, Q562E7, Q5ND34, Q6VNB8, Q6ZNJ1, Q6ZQA0, Q6ZS30, Q6ZS81, Q7LKZ7, Q86JF2, Q8IZQ1, Q8NFP9, Q92636, Q99698, Q9DDD5, Q9EPN1, Q9ESE1, Q9TTK4, Q9W060, Q9W4E2, E7FEV0, F4JY12, Q10122

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 23 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Macroautophagy634.6×2e-06

GO biological processes:

GO termPartnersFoldFDR
autophagosome maturation695.8×2e-09
mitophagy686.7×3e-09
autophagosome assembly661.3×2e-08

Disease & clinical

Clinical variants and AI predictions

ClinVar

162 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance115
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

4504 predictions. Top by Δscore:

VariantEffectΔscore
8:58585646:GCTTA:Gdonor_loss1.0000
8:58585647:CTTA:Cdonor_loss1.0000
8:58585648:TTACC:Tdonor_loss1.0000
8:58585649:TA:Tdonor_loss1.0000
8:58586481:ACAAT:Adonor_gain1.0000
8:58586482:CAATC:Cdonor_gain1.0000
8:58586486:C:Adonor_gain1.0000
8:58587617:CA:Cdonor_gain1.0000
8:58589874:T:Cdonor_gain1.0000
8:58594286:CTGCT:Cacceptor_gain1.0000
8:58595558:A:ACdonor_gain1.0000
8:58595558:ACT:Adonor_gain1.0000
8:58595559:C:CTdonor_gain1.0000
8:58595559:CT:Cdonor_gain1.0000
8:58595559:CTC:Cdonor_gain1.0000
8:58595559:CTCT:Cdonor_gain1.0000
8:58595588:A:Cdonor_gain1.0000
8:58595657:CAC:Cacceptor_gain1.0000
8:58595659:CCTG:Cacceptor_loss1.0000
8:58595660:C:CCacceptor_gain1.0000
8:58595660:C:CGacceptor_loss1.0000
8:58595661:T:Aacceptor_loss1.0000
8:58597436:TTTAA:Tdonor_gain1.0000
8:58597901:TA:Tacceptor_gain1.0000
8:58597903:C:CCacceptor_gain1.0000
8:58599257:C:CAdonor_gain1.0000
8:58599748:A:ACdonor_gain1.0000
8:58599749:C:CTdonor_gain1.0000
8:58599749:CT:Cdonor_gain1.0000
8:58599866:ATTAA:Aacceptor_gain1.0000

AlphaMissense

6107 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:58597499:A:CF560L1.000
8:58597499:A:TF560L1.000
8:58597501:A:GF560L1.000
8:58597497:C:TG561E0.999
8:58599292:A:GW509R0.999
8:58599292:A:TW509R0.999
8:58599973:T:AK443N0.999
8:58599973:T:GK443N0.999
8:58599974:T:AK443I0.999
8:58601296:T:AR423S0.999
8:58601296:T:GR423S0.999
8:58601297:C:GR423T0.999
8:58601309:T:AD419V0.999
8:58601310:C:GD419H0.999
8:58601449:C:AR404S0.999
8:58601449:C:GR404S0.999
8:58601450:C:AR404M0.999
8:58601450:C:GR404T0.999
8:58601491:A:CS390R0.999
8:58601491:A:TS390R0.999
8:58601493:T:GS390R0.999
8:58601503:G:CF386L0.999
8:58601503:G:TF386L0.999
8:58601505:A:GF386L0.999
8:58603243:A:GW338R0.999
8:58603243:A:TW338R0.999
8:58603281:C:GR325P0.999
8:58603340:C:AW305C0.999
8:58603340:C:GW305C0.999
8:58603342:A:GW305R0.999

dbSNP variants (sampled 300 via entrez): RS1000130367 (8:58652132 T>C), RS1000162429 (8:58655499 G>A), RS1000264512 (8:58612766 C>A,T), RS1000296121 (8:58655247 C>T), RS1000328957 (8:58643222 C>T), RS1000355814 (8:58629774 T>A,C), RS1000378101 (8:58622514 C>T), RS1000401865 (8:58598273 G>C), RS1000410775 (8:58622860 G>A), RS1000419218 (8:58606535 C>T), RS1000497984 (8:58656398 A>C), RS1000503151 (8:58614314 A>G), RS1000535432 (8:58607581 A>G), RS1000553694 (8:58635910 C>A), RS1000558921 (8:58598504 A>C,G)

Disease associations

OMIM: gene MIM:603043 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST009066_15Mosaic loss of chromosome Y (Y chromosome dosage)4.000000e-08
GCST012189_9Systolic blood pressure and diastolic blood pressure (bivariate analysis)6.000000e-06
GCST90002379_120Basophil count2.000000e-09

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0007783mosaic loss of chromosome Y measurement
EFO:0006335systolic blood pressure
EFO:0006336diastolic blood pressure
EFO:0005090basophil count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: enzyme — Neutral sphingomyelinase coupling factors

CTD chemical–gene interactions

44 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression, affects expression7
trichostatin Aaffects expression, increases expression2
(+)-JQ1 compoundaffects expression, increases reaction, decreases expression2
Benzo(a)pyrenedecreases expression2
Doxorubicindecreases expression, affects response to substance2
aristolochic acid Idecreases expression1
triphenyl phosphateaffects expression1
pirinixic acidaffects binding, increases activity, increases expression1
bisphenol Aaffects cotreatment, decreases methylation1
arseniteaffects binding, increases reaction1
sodium arseniteincreases expression1
propionic aciddecreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
perfluoro-n-nonanoic acidincreases expression1
2-palmitoylglycerolincreases expression1
entinostatdecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
ICG 001increases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, increases expression1
dorsomorphinaffects cotreatment, decreases expression1
Irinotecandecreases expression1
Temozolomidedecreases expression1
Sunitinibincreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Vorinostatdecreases expression1
Panobinostataffects expression, increases reaction1
Air Pollutantsincreases expression, increases abundance1
Atrazinedecreases expression1
Benzeneincreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_W802PC-53Cancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.